Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARYS-01 (sorivudine) cream for Herpes Zoster
NCT00652184Phase 2Unknown
- Sponsor
- aRigen Pharmaceuticals, Inc.
- Start
- Mar 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ARYS-01 in herpes zoster (HZ), sponsored by aRigen Pharmaceuticals, Inc.. Status: unknown.
02
Drugs
ARYS-01
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT00652184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00652184.